Literature DB >> 25144113

Detection and surveillance of viral hemorrhagic septicemia virus using real-time RT-PCR. II. Diagnostic evaluation of two protocols.

Janet V Warg1, Travis Clement, Emily R Cornwell, Angela Cruz, Rodman G Getchell, Cem Giray, Andrew E Goodwin, Geoffrey H Groocock, Mohamed Faisal, Robert Kim, Gwenn E Merry, Nicholas B D Phelps, Monica M Reising, Isaac Standish, Yan Zhang, Kathy Toohey-Kurth.   

Abstract

Two real-time reverse transcription polymerase chain reaction (rRT-PCR) assays under consideration for deployment to multiple testing laboratories across the USA were evaluated for diagnostic sensitivity and specificity on tissue homogenates obtained from natural and experimental viral hemorrhagic septicemia (VHS)-infected fish. Estimates for diagnostic specificity using virus isolation as the reference method were similar between laboratories regardless of the assay. Diagnostic sensitivity estimates of 0.96 (95% CI: 0.95, 0.97) for Jonstrup et al. (2013)'s assay (J Fish Dis 36:9-23) exceeded the diagnostic sensitivity of 0.85 (95% CI: 0.83, 0.87) for Phelps et al. (2012)'s assay (J Aquat Anim Health 24:238-243). The Jonstrup rRT-PCR assay is robust as demonstrated by high sensitivity and specificity estimates across laboratories and can be used as a valuable tool for targeted surveillance and for testing of suspect VHSV samples.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144113     DOI: 10.3354/dao02758

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  1 in total

1.  Suggested guidelines for validation of real-time PCR assays in veterinary diagnostic laboratories.

Authors:  Kathy Toohey-Kurth; Monica M Reising; Rebecca L Tallmadge; Laura B Goodman; Jianfa Bai; Steven R Bolin; Janice C Pedersen; Mangkey A Bounpheng; Roman M Pogranichniy; Jane Christopher-Hennings; Mary Lea Killian; Donna M Mulrooney; Roger Maes; Shri Singh; Beate M Crossley
Journal:  J Vet Diagn Invest       Date:  2020-09-28       Impact factor: 1.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.